Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation

• Status: Completed
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the dermal sensitization potential of azelaic acid pre-foam formulation.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bayer; LEO Pharma
• Collaborator: Bayer
• Treatments: Azelaic acid

Criteria

Inclusion Criteria:

• healthy volunteers

• male or female subjects

• aged 18 - 65 years

• ability to understand and fulfill the study requirements

Exclusion Criteria:

• affected skin in designated test area

• pregnancy or lactation

• not willing to comply with study requirements